Together, these results provide genetic evidence that rare variants across multiple lysosomal pathways, particularly those related to sialylation, ganglioside metabolism, ceramide biology, and lysosomal proteolysis, may contribute to Parkinson's disease susceptibility beyond <i>GBA1</i>, highlighting biologically coherent pathways for future replication and functional investigation. The gene discussed is GBA1; the disease is Parkinson disease.